Stemcell Technologies

Overview

Stemcell Technologies, founded in 1993 and headquartered in Canada, operates within the manufacturing sector, specifically focusing on chemicals and related products as well as biotechnology and pharmaceuticals. The company employs between 1,001 and 5,000 individuals and has reported significant revenue. Stemcell Technologies specializes in providing products and services that support the development of cell and gene therapies. A key aspect of their offerings is the Services for Cell Therapy Program, which assists clients in navigating the complexities of developing ancillary materials necessary for clinical trials and commercialization. This program emphasizes collaboration with clients, including small biotech firms and large pharmaceutical companies, to tailor solutions that meet specific clinical needs. The company also provides custom manufacturing and testing services, ensuring compliance with quality control standards and offering documentation such as Certificates of Origin and Certificates of Analysis. Through these initiatives, Stemcell Technologies aims to be a reliable partner in advancing innovative therapies for patients.

Industry